Gabapentinoids and Risk for Severe Exacerbation in Chronic Obstructive Pulmonary Disease

North American and European health agencies recently warned of severe breathing problems associated with gabapentinoids, including in patients with chronic obstructive pulmonary disease (COPD), although supporting evidence is limited.